Locally Advanced Unresectable Gastric Adenocarcinoma Cancer
1 clinical trials · Condition
◉ Watch Locally Advanced Unresectable Gastric Adenocarcinoma Cancer
| Record | Firm | Date |
|---|---|---|
| Early Access Program for Zolbetuximab (NCT06048081) | Astellas Pharma Global Development, Inc. |
Track Locally Advanced Unresectable Gastric Adenocarcinoma Cancer automatically
Every clearance here is in the API, with alerts when new ones post.